Document Detail


Calcium binding by human erythrocyte membranes. Significance of carboxyl, amino and thiol groups.
MedLine Citation:
PMID:  5158916     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
1. The role of the ionized carboxyl groups of proteins of the erythrocyte membrane as Ca(2+) receptor sites was investigated. A water-soluble carbodi-imide [1-cyclohexyl-3-(2-morpholinoethyl)carbodi-imide methotoluene-p-sulphonate], referred to as carbodi-imide reagent, and glycine methyl ester were used to modify the free carboxyl groups of the membrane. The degree of modification was estimated from amino acid analyses, which showed the amount of glycine incorporated. As the concentration of carbodi-imide reagent was raised (0.1-0.4m) incorporation of glycine increased and Ca(2+) binding decreased by about 77%. At 0.4m-carbodi-imide reagent all of the binding of Ca(2+) to protein was abolished and it was estimated that about 37% of the side-chain carboxyl groups of aspartic acid plus glutamic acid had been blocked by glycine. 2. Acetylation of all of the free amino groups was achieved by incubating the erythrocyte ;ghosts' at pH10.3 with acetic anhydride (10-15mg/10mg of ;ghost' protein). Acetylation increased by 1.5-fold the capacity of the ;ghost' to bind Ca(2+), indicating that the remaining carboxyl groups of aspartic acid and glutamic acid were made available for Ca(2+) binding by this procedure. These findings support the concept that in normal ;ghosts', at pH7.4, Ca(2+) binding to free carboxyl groups is partially hindered by the presence of charged amino groups. 3. Treatment of ;ghosts' with N-acetylneuraminidase, which removed 94% of sialic acid residues, and treatment with 1mm-p-chloromercuribenzoate did not alter Ca(2+) binding. The major effect of 5.8mm-p-chloromercuribenzoate upon ;ghosts' was to cause a solubilization of a calcium-membrane complex, which included about one-third of the ;ghost' protein. The molar ratio of Ca(2+): protein in the solubilized material was the same as that in the intact (untreated) ;ghosts'.
Authors:
J Forstner; J F Manery
Related Documents :
24442706 - The biosynthesis of a c19-gibberellin from mevalonic acid in a cell-free system from a ...
6667476 - 13c-n.m.r.-spectral study of the mode of binding of gd3+ to various glycopeptides.
15755156 - Total synthesis and properties of the crambescidin core zwitterionic acid and crambesci...
11667476 - Electronic factors influencing the decarboxylation of beta-keto acids. a model enzyme s...
23383696 - Polyphenolic composition of the leaves of zanthoxylum bungeanum maxim. grown in hebei c...
23124096 - Overexpression of dyrk1a inhibits choline acetyltransferase induction by oleic acid in ...
Publication Detail:
Type:  In Vitro; Journal Article    
Journal Detail:
Title:  The Biochemical journal     Volume:  125     ISSN:  0264-6021     ISO Abbreviation:  Biochem. J.     Publication Date:  1971 Nov 
Date Detail:
Created Date:  1972-04-26     Completed Date:  1972-04-26     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  2984726R     Medline TA:  Biochem J     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  343-52     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amino Acids / analysis
Aspartic Acid
Binding Sites*
Blood Proteins
Calcium / metabolism*
Calcium Isotopes
Cell Membrane / metabolism*
Chloromercuribenzoates
Erythrocytes / metabolism*
Glutamates
Glycine / analysis
Humans
Neuraminic Acids
Neuraminidase
Protein Binding
Chemical
Reg. No./Substance:
0/Amino Acids; 0/Blood Proteins; 0/Calcium Isotopes; 0/Chloromercuribenzoates; 0/Glutamates; 0/Neuraminic Acids; 56-40-6/Glycine; 56-84-8/Aspartic Acid; 7440-70-2/Calcium; EC 3.2.1.18/Neuraminidase
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Digestion of an exogenous protein by rat yolk-sac cultured in vitro.
Next Document:  Further studies on the glycerol teichoic acid of walls of Staphylococcus lactis I3. Location of the ...